The Horizons Tracker

NOVEMBER 29, 2023

However, the research also highlights the significance of diverse educational, industrial, and organizational backgrounds among managers and board members in fostering innovation in research and development (R&D), thereby generating both economic and social value.

Diversity 96

Diversity Innovation Biotechnology Short-term 96

Harvard Business Review

APRIL 2, 2018

There is an abundance of high-quality comparative effectiveness data for pharmaceuticals, largely because of the drug approval process, but there’s less data on the value of other expensive investments into health, such as doctor visits and hospitalizations. (For

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

AUGUST 3, 2012

They might make a targeted acquisition here or there, form an alliance now and again, or license in some specialized technology, but by and large they made their own drugs, supporting big, fully staffed research labs, which they would then market themselves. As yet, the facts don't seem to substantiate the fears.

Licensing 12

Licensing Depreciation Pharmaceuticals Budgeting 12

Harvard Business Review

JULY 4, 2017

Apple is so great at connectivity, aesthetics, and entertainment that any vehicle they develop will incorporate these as table stakes. With that in mind, I can see three potential scenarios for how Apple might play in the autonomous car market. The first scenario is to enter cars as a Trojan horse to sell more iPhones. Or a kitchen?

Transportation 9

Transportation Sports Pharmaceuticals Health Care 9

Harvard Business Review

OCTOBER 20, 2016

Meanwhile the Institute of International Finance forecasted net capital flows for emerging markets in 2015 would be negative for the first time since 1988. pharmaceutical company, had to abandon its $106 billion attempt to buy British drug maker AstraZeneca in the face of opposition from UK politicians.

Globalization 8

Globalization Banking Policies Politics 8

Harvard Business Review

OCTOBER 13, 2011

Bank marketing materials focus on the dreams, anxieties and goals of consumers. The pharmaceutical industry also creates products with complex interactions and potentially dangerous side effects. Yet unlike in finance, where distributing risk across institutions is the goal, in drug development the focus is on isolating risk.

Banking 10

Banking Pharmaceuticals Microfinance Risk Management 10

Harvard Business Review

APRIL 19, 2016

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. Moving forward, consider the following questions for strategic development: Opportunity analysis. What would be the cost/benefit of flattening your supply chain and moving production closer to your markets?

Supply Chain 8

Supply Chain Execution Analysis Technology 8

Harvard Business Review

JUNE 16, 2016

In July 2015, Novartis launched its new heart failure drug, Entresto, which Forbes in 2014 predicted would be a blockbuster — with expected sales of $10 billion annually — as the potential market in the US exceeds 5 million people with a heart failure condition. The failure stemmed from resistance in the U.S.

Planning 8

Planning Competitive Intelligence Pharmaceuticals Brand 8

Harvard Business Review

AUGUST 2, 2011

In reality, each country needs the other to succeed in order to thrive — to finance growth, secure export markets, train talent, transfer technology, and more. For example, pharmaceutical firms license compounds to each other and co-promote products in different markets. Facilitate discussion between competitors.

Apparel 15

Apparel Pharmaceuticals Finance Licensing 15

Harvard Business Review

MAY 5, 2016

But peruse some of the recent headlines about Iran , and you might wonder whether the market’s potential was overstated. However, despite a weakened economy, political tensions, market uncertainty, and the lingering effects of sanctions, Iran remains an important opportunity for multinationals in emerging markets.

Tourism 8

Tourism Banking Due Diligence Hotels 8

Harvard Business Review

AUGUST 23, 2018

In addition to signaling a strong economy, a tight labor market typically improves job prospects for groups with fewer skills and less experience, including teens. But for those who might not be college-bound, it appears that fewer pathways exist to enter the labor market. However, as of July 2018, the U.S. Refocusing on Summer Jobs.

Short-term 8

Short-term Participative Long-term Career 8

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. It’s not just products.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

OCTOBER 25, 2018

We focus on economic profit rather than revenue size, market share, or productivity growth because these other metrics risk including firms that are simply large and may not create economic value. Often when superstar cities fall, they tend to be advanced economy cities, replaced by a developing economy city.

Industry 12

Industry Company GDP Bottom-up 12

Harvard Business Review

APRIL 5, 2012

If you spend much time around salespeople, it won't take long before you hear them griping about the issue that is the profession's biggest trouble spot: disagreement over the market potential of a group of accounts or a territory. In exit interviews, the people who leave imply they don't have enough market potential to succeed.".

Retail 9

Retail Incentives Tactics Pharmaceuticals 9

Harvard Business Review

MAY 1, 2013

Without adequate financing, ministries of health and even private hospitals in developing countries often don''t have the resources needed to purchase diagnostic equipment, train workers, and ensure access to appropriate treatment. Resistant forms continue to thrive, and increased travel makes the global threat very real. Redefine ROI.

Health Care 8

Health Care ROI NGO Long-term 8

Harvard Business Review

SEPTEMBER 21, 2015

Terry, a highly regarded marketing associate in a pharmaceutical firm, had just been asked to lead a marketing team. To do this, Terry drew on her own experience as a star marketer. She met with these managers to develop a set of service level agreements for how their functions would work together.

Management 8

Management Pharmaceuticals Learning-by-Doing Marketing 8

Harvard Business Review

JUNE 29, 2015

If you ask someone who works in finance (as I had to) about PE and innovation, he or she will likely tell you that PE sponsors aren’t looking for the next big thing—they’re looking for companies that are dominant in a market, aren’t risky, and have a predictable and steady stream of cash to pay back debt.

LBO 8

LBO Innovation Sample Short-term 8

Harvard Business Review

NOVEMBER 9, 2011

COOs are relatively common in service industries such as financial services, energy, information technology and telecommunications, but in manufacturing sectors — such as automotive, chemical, and pharmaceutical companies — they are relatively rare.

COO 12

COO Sample Telecommunications Automotive 12

Harvard Business Review

SEPTEMBER 5, 2016

The UK’s Department for International Development uses “results-based” aid to improve the educational outcomes of young girls in Africa and Asia. Cigna is the first insurance company to get pharmaceutical companies to agree to value pricing based on results for certain cholesterol-lowering drugs. ” Health care.

Incentives 8

Incentives Health Care Education Insurance 8

Harvard Business Review

JANUARY 26, 2011

Companies included in the ETF include major airlines, pharmaceuticals, industrials, and technology. By the end of October in 2010, the market value of the 100 constituent stocks reached 582 billion RMB, accounting for 31% of the total market value of the Shanghai Stock Exchange's A shares.

Long-term 14

Long-term Sample Report Pharmaceuticals 14

Harvard Business Review

FEBRUARY 24, 2015

The first category is exogenous factors over which the business has little control: the growth of the markets into which it sells; the competitive intensity and thus the average profitability of the industry in which it operates; or the fragmentation of its industry and thus the scope for a growth-by-acquisition approach.

Chemicals 8

Chemicals How To Kahneman Reputation 8

Harvard Business Review

FEBRUARY 4, 2013

Just under 1,000 companies account for half of the world's market capitalization, Eccles notes. Levi Strauss, intriguingly, has used biomimetic techniques in developing new production techniques for jeans. Breakthrough requires an end to systemic inequities by opening up processes, information - and markets.

EPS 8

EPS Innovation CEO Pharmaceuticals 8

Harvard Business Review

MAY 15, 2013

Nor can we develop good approaches to analyzing, preserving and transforming cultures. If we can define what organizational culture is , it gives us a handle on how to diagnose problems and even to design and develop better cultures. finance vs. marketing) and units (e.g.

Incentives 8

Incentives Definition Pharmaceuticals System 8

Harvard Business Review

SEPTEMBER 4, 2015

However, CEOs often don’t have the career background and education that would equip them to personally lead the process of new product development. We found that, for pharmaceutical industry CEOs, there is a statistically significant relationship between a CEO’s specialist background and the firm’s performance.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

OCTOBER 24, 2014

In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. HR has the job of developing the human capabilities needed to capture the IoT opportunity.

Productivity 8

Productivity Products Company Engineering 8

Harvard Business Review

NOVEMBER 20, 2015

He is poised to become the leader in this segment of a multi-billion dollar market. Compliance is crucial for pharmaceutical makers such as Abbott and Amgen – a “ Form 483 ” warning from an FDA inspector can shut down a drug facility in an instant and even land top executives in jail.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 19, 2016

This logic and the institutions that reinforce it, like competitive markets and the rule of law, have transformed the world and lifted billions of people from poverty. Imagine, for example, that you’re a pharmaceutical CEO deciding whether to recall a new drug. How should you make this decision?

ROI 8

ROI Long-term Conflict of Interest Pharmaceuticals 8

Harvard Business Review

JANUARY 26, 2016

And yet for almost every company that uses CI in their decision-making, there’s another that disregards CI’s mix of industry analysis, rival positions, and market insight to their detriment. and European corporations, from CI-trained analysts in marketing, business development, strategy, R&D, finance, and other fields.

Competitive Intelligence 8

Competitive Intelligence Company CAPEX Analysis 8

Harvard Business Review

DECEMBER 12, 2018

Research we have conducted has revealed a variety of new, highly impactful investment approaches that can help accelerate the pace of the development, approval, and commercialization of new cancer therapies. In this approach, drug discovery is developed around a specific disease and is financed by the efforts of a disease-focused foundation.

Pharmaceuticals 8

Pharmaceuticals Venture Funding Finance Development 8

Harvard Business Review

JUNE 20, 2017

The possibility of a contentious renegotiation of the North American Free Trade Agreement (NAFTA) has led to delayed or canceled investments in what has been one of Latin America’s most economically stable markets. Renegotiating NAFTA. So, if a company manufactures products in Mexico to export to Canada and the U.S.

Supply Chain 8

Supply Chain Depreciation Uncertainty Marketing 8